Conference Insights
A Multi-center, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Kerecis® Fish Skin in the Treatment of Chronic, Non-Responsive Diabetic Foot Ulcers
05/06/2021
Presented by: John C. Lantis, MD
Intact fish skin is a piscine dermal (xenograft) which retains its native dermal structure and a high concentration of Omega3 fatty acids. Preclinical work has shown that the acellular native dermal structure supports cellular ingrowth, and the Omega3 fatty acids are bacteriostatic. Early clinical work has shown efficacy in acute wounds in healthy volunteers, venous leg ulcers, mixed etiology wounds and diabetic foot ulcers. This poster presentation reports the findings of the first prospective multicenter randomized controlled trial evaluating the effects of Omega3 rich fish skin for treatment of diabetic foot ulcers.
